Sign in
4

Changes in Ownership

Pyxis Oncology, Inc. Filed Acc 0001209191-23-049826

President and CEO sold 8,641 shares at an average $2.10 ($18,161)

From the SEC's structured data for this filing

Trades in this filing

Sullivan Lara · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-14 Sale : show line 1 in the form −100 $2.25 $225 2,412,423 D
2023-09-18 Sale : show line 2 in the form −8,541 $2.10 $17,936 2,403,882 D
Open-market sales · 8,641 sh · avg $2.10 · $18,161
Loading xslF345X05/doc4.xml…